Literature DB >> 15887861

Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.

D Olchovsky1, D Ezra, I Vered, M Hadani, I Shimon.   

Abstract

Hyponatremia associated with high urine osmolality is usually caused by inappropriate secretion of antidiuretic hormone. However, secondary hypoadrenalism is also accompanied by hyponatremia and with features indistinguishable from the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). As secondary hypoadrenalism requires a specific treatment, a high index of suspicion and appropriate hormonal testing are required to differentiate between these two entities. We retrospectively studied 10 patients with a previously undiagnosed hypothalamic-pituitary disease who presented with an acute symptomatic hyponatremia. Mean age (+/-SD) was 65.1+/-8.4 yr. Mean serum sodium was 120.7+/-2.9 nmol/l and urinary osmolality, 453.9+/-74 mosmol/kg. Serum creatinine, urea and uric acid were low. Mean serum morning cortisol was low, 104.0+/-55.2 nmol/l. High-dose ACTH test showed adequate increment of serum cortisol in 3 out of 7 patients tested. Two of these 3 patients did not respond adequately to the low-dose ACTH test. Endocrine evaluation disclosed partial or complete hypopituitarism in all 10 patients. Six patients had pituitary macroadenomas, one had a craniopharyngioma, one patient had a large aneurysm of the internal carotid with sellar destruction and two others had empty sella. Treatment by fluid restriction did not affect serum sodium levels significantly. In contrast, all patients achieved normal sodium when treated by glucocorticosteroid. Central hypoadrenalism should be considered in any patient presenting with hyponatremia with high urine osmolality. Low-dose ACTH test should be performed and followed by appropriate endocrine and imaging studies. Hyponatremia in these patients is promptly corrected by glucocorticosteroid replacement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887861     DOI: 10.1007/bf03345358

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Corticotropin deficiency: a rare cause of hyponatremia mimicking SIADH.

Authors:  E A De Leacy; S Bowler; J M Brown; D M Cowley
Journal:  Pathology       Date:  1991-01       Impact factor: 5.306

Review 2.  Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age.

Authors:  Philippe Chanson
Journal:  Eur J Endocrinol       Date:  2003-09       Impact factor: 6.664

3.  Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.

Authors:  J Mayenknecht; S Diederich; V Bähr; U Plöckinger; W Oelkers
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

4.  Hospital-associated hyponatremia.

Authors:  R J Anderson
Journal:  Kidney Int       Date:  1986-06       Impact factor: 10.612

Review 5.  The hyponatremic patient: a systematic approach to laboratory diagnosis.

Authors:  Haralampos J Milionis; George L Liamis; Moses S Elisaf
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

6.  Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.

Authors:  T Saito; A Fukagawa; M Higashiyama; T Nakamura; I Kusaka; S Nagasaka; K Honda; T Saito
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

7.  Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function.

Authors:  M Zarković; J Cirić; M Stojanović; Z Penezić; B Trbojević; M Drezgić; M Nesovic
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

8.  Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency.

Authors:  Toshimitsu Yatagai; Ikuyo Kusaka; Tomoatsu Nakamura; Shoichiro Nagasaka; Kazufumi Honda; Shun Ishibashi; San-e Ishikawa
Journal:  Eur J Endocrinol       Date:  2003-02       Impact factor: 6.664

9.  The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.

Authors:  K Tordjman; A Jaffe; N Grazas; C Apter; N Stern
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

10.  Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency.

Authors:  K Kamoi; T Tamura; K Tanaka; M Ishibashi; T Yamaji
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

View more
  5 in total

1.  Beyond semantics: defining hyponatremia in secondary adrenal insufficiency.

Authors:  M Faustini-Fustini; M Anagni
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

2.  Syndrome of inappropriate secretion of antidiuretic hormone as an initial sign of primary central nervous system lymphomas in the hypothalamus.

Authors:  Masahiro Oishi; Yasuhiko Hayashi; Yasuo Sasagawa; Nozomu Oikawa; Mitsutoshi Nakada
Journal:  Acta Neurol Belg       Date:  2022-06-18       Impact factor: 2.396

3.  Craniopharyngioma presenting with severe hyponatremia, hyponatremia-induced myopathy, and panhypopituitarism: a case report.

Authors:  M D S A Dilrukshi; G V N Sandakumari; P K Abeysundara; T Chang
Journal:  J Med Case Rep       Date:  2017-02-05

Review 4.  Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?

Authors:  Antonios H Tzamaloukas; Joseph I Shapiro; Dominic S Raj; Glen H Murata; Robert H Glew; Deepak Malhotra
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

5.  Renal tubular acidosis complicated with hyponatremia due to cortisol insufficiency.

Authors:  Yuichiro Izumi; Yushi Nakayama; Tomoaki Onoue; Hideki Inoue; Masashi Mukoyama
Journal:  Oxf Med Case Reports       Date:  2015-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.